Pain management medication Darvon, another brand version of Darvocet has been withdrawn from the U.S. market at the request of U.S. Food and Drug Administration. The FDA has also informed generic manufacturers of propoxyphene-containing products of this decision and requested that those drugs be voluntarily remove their products as well.
Market recall of propoxyphene was based on new clinical data showing that the drug puts patients at risk of potential serious or even fatal heart rhythm abnormalities. Combined with other information, including new epidemiological data, the agency concluded that the risk of the medication outweigh the benefits.
Insights On The Law
Read our newsletters here.
DePuy Hip Implant Recall
Despite considerable criticism and two years of complaints that the ASR Artificial Hip was failing, DePuy Orthopaedics, Inc. waited until August of 2010 to announce a recall. Known as the ASR XL Acetabular and ASR Hip Resurfacing System, these ASR hips have been implanted in over 93,000 patients.
Due to the premature failure of DePuy Hips, up to 12.5% (approximately one in eight) of patients may be forced to endure the pain and associated expenses of subsequent corrective surgery.
An osteoporosis drug intended to strengthen bones and reduce the risk of fractures has been linked to increased femur bone fractures and osteonecrosis of the jaw, a condition that causes abnormal bone deterioration.
Knee replacement failure, revision surgery, loosening of the implant after replacement and knee pain or knee complications are some of the reports that are driving concerns regarding Zimmer NexGen CR and NexGen CR-Flex knee replacement components.
A smoking cessation medication designed to help adults quit smoking has been linked to blackouts, potential suicidal thoughts, and suicide in itself.
Call (800) FAIR-PLAY or simply visit the contact us page for other contact methods.